Teewinot Life Sciences' Series B Round

Teewinot Life Sciences raised a round of funding on May 01, 2017. Investors include Tuatara Capital.

Teewinot Life Sciences, formerly CBC Biotechnologies, is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed pat…

Articles about Teewinot Life Sciences' Series B Round: